|
시장보고서
상품코드
1462978
경피 약물전달 시스템 시장, 점유율, 규모, 동향 및 산업 분석 보고서 : 유형별, 기술별, 용도별, 지역별, 부문별 예측(2024-2032년)Transdermal Drug Delivery Systems Market Share, Size, Trends, Industry Analysis Report, By Type (Transdermal Patches, Transdermal Semisolids); By Technology; By Application; By Region; Segment Forecast, 2024- 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면, 경피 약물전달 시스템 세계 시장 규모는 2032년까지 400억 1,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
의료비 지출 증가와 대체 약물전달 방법에 대한 인식이 높아지면서 경피적 약물전달 시스템 시장이 성장하고 있습니다. 전 세계적으로 의료비 지출이 증가함에 따라 환자 치료 결과를 개선하는 비용 효율적인 치료법에 대한 수요가 증가하고 있습니다. 경피 약물전달 시스템은 기존 방법보다 우수하기 때문에 많은 지지를 받고 있습니다. 경피약물전달시스템은 약물의 방출을 제어하고 지속시켜 약물의 효능을 높이고 부작용을 최소화할 수 있습니다. 비침습적이고 통증이 없는 경피 패치는 환자에게 편안함과 복약 순응도를 제공합니다.
처방전 없이 구입할 수 있는 일반의약품(OTC)은 가벼운 질병을 스스로 치료하는 데 점점 더 선호되고 있습니다. 편리한 약물 치료 옵션과 셀프 케어에 대한 수요 증가로 OTC 시장은 강력한 성장세를 보이고 있습니다. 경피 약물전달 시스템은 OTC 분야에서 사용 편의성과 부작용이 적다는 장점을 제공합니다. 소비자들은 집에서 쉽게 패치를 붙일 수 있으며, 이는 신뢰할 수 있고 편리한 치료 옵션을 중시하는 OTC 시장과 일치합니다. 소비자의 인식이 높아지고 더 많은 제품이 출시됨에 따라 경피 약물전달 시스템에 대한 수요가 증가할 것으로 예상됩니다.
경피적 호르몬 대체 요법(HRT)에 대한 선호도가 경피적 약물전달 시스템 시장을 주도하고 있습니다. 갱년기 증상 완화에 자주 사용되는 경피적 HRT는 기존 방식에 비해 장점이 있습니다. 경피 패치는 소화기관과 간 대사를 우회하여 피부를 통해 직접 호르몬을 투여하기 때문에 호르몬 수치가 안정적이고 부작용이 적습니다. 편리하고 사용하기 쉬운 패치는 의료진을 자주 방문 할 필요가 없어 환자의 순응도를 높일 수 있습니다. 눈에 잘 띄지 않고 편안하기 때문에 환자와 의료 서비스 제공업체 사이에서 점점 더 인기를 얻고 있습니다.
경피약물전달시스템 시장은 피부과 및 화장품 분야로의 적용 확대로 성장하고 있습니다. 건선, 여드름 등의 증상을 타겟으로 전신 부작용을 최소화합니다. 또한, 경피 패치는 항산화제나 비타민과 같은 스킨케어 성분을 전달하기 위해 화장품 분야에서 인기가 높아지고 있습니다. 이 패치는 방출이 잘 조절되어 피부에 오래 지속되는 효과를 제공합니다. 피부 질환의 유병률 증가, 피부 관리에 대한 소비자의 인식 증가, 비침습적 약물전달 방법에 대한 수요 등의 요인이 시장 성장을 가속하고 있습니다.
경피적 약물전달 시스템 시장 보고서 하이라이트
2023년 경피 패치 분야는 사용의 용이성, 편의성, 환자의 순응도 등으로 인해 큰 매출 점유율을 차지할 것으로 예상됩니다.
이온포레시스 분야는 2023년 효율적인 약물전달, 흡수 촉진, 임상 적용 확대로 인해 큰 매출 점유율을 차지할 것으로 예상됩니다.
2023년 통증 관리 분야는 만성통증 발생률 증가, 표적 치료, 환자 선호도 증가로 인해 큰 매출 비중을 차지할 것으로 예상됩니다.
2023년 북미는 선진화된 의료 인프라, 높은 의료비, 주요 시장 기업의 존재로 인해 세계 시장을 장악했습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 경피 약물전달 시스템 시장 인사이트
- 경피 약물전달 시스템 시장 - 용도 현황
- 경피 약물전달 시스템 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 경피 약물전달 시스템 시장 용도 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 기술별 세계 시장
- 주요 조사 결과
- 서론
- Iontophoresis
- Electroporation
- 초음파
- Mechanical arrays
- 기타
제6장 유형별 세계 시장
- 주요 조사 결과
- 서론
- 경피 패치
- 경피 흡수형 반고형제
제7장 용도별 세계 시장
- 주요 조사 결과
- 서론
- 통증 관리
- 호르몬 응용
- 심혈관 질환
- 중추신경계 질환
- 기타
제8장 지역별 세계 시장
- 주요 조사 결과
- 서론
- 경피 약물전달 시스템 시장 평가, 지역별, 2019-2032년
- 경피 약물전달 시스템 시장 - 북미
- 북미 : 경피 약물전달 시스템 시장, 기술별, 2019년-2032년
- 북미 : 경피 약물전달 시스템 시장, 용도별, 2019년-2032년
- 북미 : 경피 약물전달 시스템 시장, 유형별, 2019년-2032년
- 경피 약물전달 시스템 시장 - 미국
- 경피 약물전달 시스템 시장 - 캐나다
- 경피 약물전달 시스템 시장 - 유럽
- 유럽 : 경피 약물전달 시스템 시장, 기술별, 2019-2032년
- 유럽 : 경피 약물전달 시스템 시장, 용도별, 2019-2032년
- 유럽 : 경피 약물전달 시스템 시장, 유형별, 2019-2032년
- 경피 약물전달 시스템 시장 - 영국
- 경피 약물전달 시스템 시장 - 프랑스
- 경피 약물전달 시스템 시장 - 독일
- 경피 약물전달 시스템 시장 - 이탈리아
- 경피 약물전달 시스템 시장 - 스페인
- 경피 약물전달 시스템 시장 - 네덜란드
- 경피 약물전달 시스템 시장 - 러시아
- 경피 약물전달 시스템 시장 - 아시아태평양
- 아시아태평양 : 경피 약물전달 시스템 시장, 기술별, 2019-2032년
- 아시아태평양 : 경피 약물전달 시스템 시장, 용도별, 2019년-2032년
- 아시아태평양 : 경피 약물전달 시스템 시장, 유형별, 2019년-2032년
- 경피 약물전달 시스템 시장 - 중국
- 경피 약물전달 시스템 시장 - 인도
- 경피 약물전달 시스템 시장 - 말레이시아
- 경피 약물전달 시스템 시장 - 일본
- 경피 약물전달 시스템 시장 - 인도네시아
- 경피 약물전달 시스템 시장 - 한국
- 경피 약물전달 시스템 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 경피 약물전달 시스템 시장, 기술별, 2019-2032년
- 중동 및 아프리카 : 경피 약물전달 시스템 시장, 용도별, 2019-2032년
- 중동 및 아프리카 : 경피 약물전달 시스템 시장, 유형별, 2019-2032년
- 경피 약물전달 시스템 시장 - 사우디아라비아
- 경피 약물전달 시스템 시장 - UAE
- 경피 약물전달 시스템 시장 - 이스라엘
- 경피 약물전달 시스템 시장 - 남아프리카
- 경피 약물전달 시스템 시장 - 라틴아메리카
- 라틴아메리카 : 경피 약물전달 시스템 시장, 기술별, 2019년-2032년
- 라틴아메리카 : 경피 약물전달 시스템 시장, 용도별, 2019-2032년
- 라틴아메리카 : 경피 약물전달 시스템 시장, 유형별, 2019년-2032년
- 경피 약물전달 시스템 시장 - 멕시코
- 경피 약물전달 시스템 시장 - 브라질
- 경피 약물전달 시스템 시장 - 아르헨티나
제9장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 파트너십/협업/계약/공개
제10장 기업 개요
- 3M Company
- Bayer AG
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories Ltd.
- Endo Pharmaceuticals Inc
- GlaxoSmithKline plc
- Hisamitsu Pharmaceutical Co., Inc.
- Johnson & Johnson
- MedPharm Ltd.
- Mylan N.V.
- Novartis International AG
- Noven Pharmaceuticals, Inc.
- Purdue Pharma L.P
- Teva Pharmaceutical Industries Ltd.
- UCB S.A.
The global transdermal drug delivery systems market size is expected to reach USD 40.01 billion by 2032, according to a new study by Polaris Market Research. The report "Transdermal Drug Delivery Systems Market Share, Size, Trends, Industry Analysis Report, By Type (Transdermal Patches, Transdermal Semisolids); By Technology; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising healthcare spending and heightened awareness of alternative drug delivery methods are propelling the transdermal drug delivery systems market. With increasing global healthcare expenditures, there's a growing need for cost-effective treatments offering improved patient outcomes. Transdermal drug delivery systems are gaining traction for their advantages over conventional methods. They provide controlled, sustained medication release, enhancing efficacy and minimizing side effects. Non-invasive and painless, transdermal patches offer patient comfort and adherence.
OTC (Over-the-Counter) medications, available without a prescription, are increasingly preferred for self-treating minor ailments. With rising demand for convenient medication options and self-care, the OTC market is witnessing robust growth. Transdermal drug delivery systems offer advantages in the OTC sector, including ease of use and minimal side effects. Consumers can conveniently apply patches at home, aligning with the OTC market's focus on reliable and convenient treatment options. As consumer awareness increases and more products become available, the demand for transdermal drug delivery systems is expected to rise.
The preference for transdermal hormone replacement therapy (HRT) is driving the transdermal drug delivery systems market. Commonly used to alleviate menopausal symptoms, transdermal HRT offers advantages over traditional methods. Transdermal patches deliver hormones directly through the skin, bypassing the digestive system and liver metabolism, resulting in stable hormone levels and reduced side effects. Convenient and easy to use, patches promote patient compliance by eliminating frequent healthcare visits. Discreet and comfortable, they are increasingly popular among patients and healthcare providers.
The transdermal drug delivery systems market is growing due to expanding applications in dermatology and cosmeceuticals. It targets conditions like psoriasis and acne, minimizing systemic side effects. Additionally, transdermal patches are increasingly popular in cosmeceuticals for delivering skincare ingredients such as antioxidants and vitamins. These patches ensure controlled release, providing prolonged skin benefits. Factors like the rising prevalence of skin disorders, increasing consumer awareness about skincare, and demand for non-invasive drug delivery methods are driving the growth of the market.
Transdermal Drug Delivery Systems Market Report Highlights
In 2023, the transdermal patches segment held a significant revenue share owing to ease of use, convenience, and patient compliance.
In 2023, the iontophoresis segment held a significant revenue share owing to efficient drug delivery, enhanced absorption, and growing clinical adoption.
In 2023, the pain management segment held a significant revenue share owing to the growing incidence of chronic pain, targeted delivery, and patient preference.
In 2023, the North America region dominated the global market due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players.
The market is highly competitive owing to the existence of market players with a global presence, including Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, MedPharm Ltd., Novartis International AG, and Purdue Pharma L.P. among others.
Polaris Market Research has segmented the Transdermal Drug Delivery Systems market report based on type, technology, application, and region:
Transdermal Drug Delivery Systems, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Transdermal Patches
- Transdermal Semisolids
Transdermal Drug Delivery Systems, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Iontophoresis
- Electroporation
- Ultrasound
- Mechanical arrays
- Others
Transdermal Drug Delivery Systems, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Pain Management
- Hormonal Applications
- Cardiovascular Diseases
- CNS Disorders
- Others
Transdermal Drug Delivery Systems, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Indonesia
- South Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Transdermal Drug Delivery Systems Market Insights
- 4.1. Transdermal Drug Delivery Systems Market - Application Snapshot
- 4.2. Transdermal Drug Delivery Systems Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising prevalence of chronic diseases is projected to spur the product demand
- 4.2.1.2. Growing Geriatric Population is expected to drive transdermal drug delivery systems market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory and compliance requirements are likely to impede the market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Transdermal Drug Delivery Systems Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Transdermal Drug Delivery Systems Market, by Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 5.3. Iontophoresis
- 5.3.1. Global Transdermal Drug Delivery Systems Market, by Iontophoresis, by Region, 2019-2032 (USD Billion)
- 5.4. Electroporation
- 5.4.1. Global Transdermal Drug Delivery Systems Market, by Electroporation, by Region, 2019-2032 (USD Billion)
- 5.5. Ultrasound
- 5.5.1. Global Transdermal Drug Delivery Systems Market, by Ultrasound, by Region, 2019-2032 (USD Billion)
- 5.6. Mechanical arrays
- 5.6.1. Global Transdermal Drug Delivery Systems Market, by Mechanical arrays, by Region, 2019-2032 (USD Billion)
- 5.7. Others
- 5.7.1. Global Transdermal Drug Delivery Systems Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Transdermal Drug Delivery Systems Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 6.3. Transdermal Patches
- 6.3.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Patches, by Region, 2019-2032 (USD Billion)
- 6.4. Transdermal Semisolids
- 6.4.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Semisolids, by Region, 2019-2032 (USD Billion)
7. Global Transdermal Drug Delivery Systems Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 7.3. Pain Management
- 7.3.1. Global Transdermal Drug Delivery Systems Market, by Pain Management, By Region, 2019-2032 (USD Billion)
- 7.4. Hormonal Applications
- 7.4.1. Global Transdermal Drug Delivery Systems Market, by Hormonal Applications, By Region, 2019-2032 (USD Billion)
- 7.5. Cardiovascular Diseases
- 7.5.1. Global Transdermal Drug Delivery Systems Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Billion)
- 7.6. CNS Disorders
- 7.6.1. Global Transdermal Drug Delivery Systems Market, by CNS Disorders, By Region, 2019-2032 (USD Billion)
- 7.7. Others
- 7.7.1. Global Transdermal Drug Delivery Systems Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Transdermal Drug Delivery Systems Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Transdermal Drug Delivery Systems Market - North America
- 8.3.1. North America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.3.2. North America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.3.3. North America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.3.4. Transdermal Drug Delivery Systems Market - U.S.
- 8.3.4.1. U.S.: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.3.5. Transdermal Drug Delivery Systems Market - Canada
- 8.3.5.1. Canada: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4. Transdermal Drug Delivery Systems Market - Europe
- 8.4.1. Europe: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.3. Europe: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.4. Transdermal Drug Delivery Systems Market - UK
- 8.4.4.1. UK: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.5. Transdermal Drug Delivery Systems Market - France
- 8.4.5.1. France: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.5.3. France: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.6. Transdermal Drug Delivery Systems Market - Germany
- 8.4.6.1. Germany: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.7. Transdermal Drug Delivery Systems Market - Italy
- 8.4.7.1. Italy: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.8. Transdermal Drug Delivery Systems Market - Spain
- 8.4.8.1. Spain: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.9. Transdermal Drug Delivery Systems Market - Netherlands
- 8.4.9.1. Netherlands: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.10. Transdermal Drug Delivery Systems Market - Russia
- 8.4.10.1. Russia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5. Transdermal Drug Delivery Systems Market - Asia Pacific
- 8.5.1. Asia Pacific: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.4. Transdermal Drug Delivery Systems Market - China
- 8.5.4.1. China: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.4.3. China: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.5. Transdermal Drug Delivery Systems Market - India
- 8.5.5.1. India: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.5.3. India: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.6. Transdermal Drug Delivery Systems Market - Malaysia
- 8.5.6.1. Malaysia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.7. Transdermal Drug Delivery Systems Market - Japan
- 8.5.7.1. Japan: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.8. Transdermal Drug Delivery Systems Market - Indonesia
- 8.5.8.1. Indonesia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.9. Transdermal Drug Delivery Systems Market - South Korea
- 8.5.9.1. South Korea: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6. Transdermal Drug Delivery Systems Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.4. Transdermal Drug Delivery Systems Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.5. Transdermal Drug Delivery Systems Market - UAE
- 8.6.5.1. UAE: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.6. Transdermal Drug Delivery Systems Market - Israel
- 8.6.6.1. Israel: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.7. Transdermal Drug Delivery Systems Market - South Africa
- 8.6.7.1. South Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7. Transdermal Drug Delivery Systems Market - Latin America
- 8.7.1. Latin America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7.4. Transdermal Drug Delivery Systems Market - Mexico
- 8.7.4.1. Mexico: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7.5. Transdermal Drug Delivery Systems Market - Brazil
- 8.7.5.1. Brazil: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7.6. Transdermal Drug Delivery Systems Market - Argentina
- 8.7.6.1. Argentina: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. 3M Company
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bayer AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Boehringer Ingelheim International GmbH
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Dr. Reddy's Laboratories Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Endo Pharmaceuticals Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. GlaxoSmithKline plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Hisamitsu Pharmaceutical Co., Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Johnson & Johnson
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. MedPharm Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Mylan N.V.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Novartis International AG
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Noven Pharmaceuticals, Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Purdue Pharma L.P
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Teva Pharmaceutical Industries Ltd.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. UCB S.A.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
